首页 > 最新文献

Pharmacology & Pharmacy最新文献

英文 中文
Combined Therapy of Pioglitazone and Atorvastatin Alleviate Diabetes in Rats More Effectively than That of Mono Therapy 吡格列酮与阿托伐他汀联合治疗对糖尿病大鼠的治疗效果优于单用
Pub Date : 2014-05-13 DOI: 10.4236/PP.2014.55060
H. Ali, A. Rahman, S. Islam, A. Mamun, Shaheda Zannah, A. Alam, A. Rahman, M. Rashid
Present research was designated to investigate the hypoglycemic, hypolipidemic and antioxidant activity of the combination of pioglitazone and atorvastatin on long-term alloxan-induced diabetes rats (AIDRs). The experiments were carried out to determine blood glucose level, lipid profile, free radial scavenging activities, superoxide dismutase (SOD) and catalase in liver tissue. In addition, left ventricular (LV) hypertrophy and cardiomyocyte size were also determined by histological analysis. It was found that in short-term induction, pioglitazone significantly reduced the blood glucose level without having any considerable effect on lipid profile and antioxidant enzymes (SOD and catalase) in rats. On the other hand, atorvastatin significantly reduced total cholesterol (TC), triglyceride (TG) and low density lipoprotein cholesterol (LDL-C) with marked increase in the level of high density lipoprotein cholesterol (HDL-C) and improved activity of SOD and catalase enzymes. However, pathological changes of heart and pancreas were not observed after short-term exposure to alloxan in rats. Long-term diabetes induction resulted in LV hypertrophy and prominent shrinkage of islets of Langerhans cells. Treatment with atorvastatin in combination with pioglitazone significantly reduced the LV hypertrophy, TC, TG and LDL level whereas they noticeably increased HDL level, DPPH (1,1-Diphenyl-2-picryl-hydrazyl) free radical scavenging activity, SOD and catalase activity with satisfactory recovery of Langerhans cells. The result demonstrated that combination therapy was more effective than that of mono-therapy for preventing diabetes with cardiovascular diseases (CVD) in rats.
本研究旨在探讨吡格列酮联合阿托伐他汀对长期四氧嘧啶诱导的糖尿病大鼠(AIDRs)的降糖、降血脂和抗氧化活性。测定大鼠血糖水平、血脂水平、肝脏组织自由基清除活性、超氧化物歧化酶(SOD)和过氧化氢酶水平。此外,还通过组织学分析确定左室肥厚和心肌细胞大小。研究发现,在短期诱导下,吡格列酮显著降低了大鼠的血糖水平,而对血脂和抗氧化酶(SOD和过氧化氢酶)没有明显的影响。另一方面,阿托伐他汀显著降低总胆固醇(TC)、甘油三酯(TG)和低密度脂蛋白胆固醇(LDL-C),显著升高高密度脂蛋白胆固醇(HDL-C)水平,提高SOD和过氧化氢酶活性。然而,大鼠短期接触四氧嘧啶后,心脏和胰腺未见病理改变。长期糖尿病诱导导致左室肥大,朗格汉斯细胞胰岛明显萎缩。阿托伐他汀联合吡格列酮治疗可显著降低左室肥大、TC、TG和LDL水平,显著提高HDL水平、DPPH(1,1-二苯基-2-苦酰基-肼基)自由基清除活性、SOD和过氧化氢酶活性,使朗格汉斯细胞恢复良好。结果表明,联合治疗对大鼠糖尿病合并心血管疾病(CVD)的预防效果优于单一治疗。
{"title":"Combined Therapy of Pioglitazone and Atorvastatin Alleviate Diabetes in Rats More Effectively than That of Mono Therapy","authors":"H. Ali, A. Rahman, S. Islam, A. Mamun, Shaheda Zannah, A. Alam, A. Rahman, M. Rashid","doi":"10.4236/PP.2014.55060","DOIUrl":"https://doi.org/10.4236/PP.2014.55060","url":null,"abstract":"Present research \u0000was designated to investigate the hypoglycemic, hypolipidemic and antioxidant \u0000activity of the combination of pioglitazone and atorvastatin on long-term \u0000alloxan-induced diabetes rats (AIDRs). The experiments were carried out to \u0000determine blood glucose level, lipid profile, free radial scavenging \u0000activities, superoxide dismutase (SOD) and catalase in liver tissue. In \u0000addition, left ventricular (LV) hypertrophy and cardiomyocyte size were also \u0000determined by histological analysis. It was found that in short-term induction, \u0000pioglitazone significantly reduced the blood glucose level without having any \u0000considerable effect on lipid profile and antioxidant enzymes (SOD and catalase) \u0000in rats. On the other hand, atorvastatin significantly reduced total \u0000cholesterol (TC), triglyceride (TG) and low density lipoprotein cholesterol \u0000(LDL-C) with marked increase in the level of high density lipoprotein \u0000cholesterol (HDL-C) and improved activity of SOD and catalase enzymes. However, \u0000pathological changes of heart and pancreas were not observed after short-term \u0000exposure to alloxan in rats. Long-term diabetes induction resulted in LV \u0000hypertrophy and prominent shrinkage of islets of Langerhans cells. Treatment \u0000with atorvastatin in combination with pioglitazone significantly reduced the LV \u0000hypertrophy, TC, TG and LDL level whereas they noticeably increased HDL \u0000level, DPPH (1,1-Diphenyl-2-picryl-hydrazyl) free radical scavenging activity, \u0000SOD and catalase activity with satisfactory recovery of Langerhans cells. The \u0000result demonstrated that combination therapy was more effective than that of \u0000mono-therapy for preventing diabetes with cardiovascular diseases (CVD) in \u0000rats.","PeriodicalId":432281,"journal":{"name":"Pharmacology & Pharmacy","volume":"94 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2014-05-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"127256322","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Quality of Drugs Based on Ferrous Sulfate Dispensed in a Basic Health and Commercial Pharmacy in a City in the Amazon Region 基于硫酸亚铁的亚马逊地区某城市基层卫生和商业药房配药质量分析
Pub Date : 1900-01-01 DOI: 10.4236/pp.2022.139025
A. Mello, Marceonia Costa dos Santos, Ana Gabriela Lisboa Santos, D. T. V. Alves, D. Grisólia, A. Grisólia, Mariceli Baia Leão Barros, Fabrícia de Jesus Paiva da Fonseca, Manoel Samuel da Cruz Neto
{"title":"Quality of Drugs Based on Ferrous Sulfate Dispensed in a Basic Health and Commercial Pharmacy in a City in the Amazon Region","authors":"A. Mello, Marceonia Costa dos Santos, Ana Gabriela Lisboa Santos, D. T. V. Alves, D. Grisólia, A. Grisólia, Mariceli Baia Leão Barros, Fabrícia de Jesus Paiva da Fonseca, Manoel Samuel da Cruz Neto","doi":"10.4236/pp.2022.139025","DOIUrl":"https://doi.org/10.4236/pp.2022.139025","url":null,"abstract":"","PeriodicalId":432281,"journal":{"name":"Pharmacology & Pharmacy","volume":"47 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"123699640","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Phytochemical Analysis and Contractile Effects of Aqueous and Hydroethanolic Extracts of Anastatica hierochuntica L. (Brassicaceae) on the Isolated Uterus of Mice 芸苔科青藤水、醇提取物对小鼠离体子宫的植物化学分析及收缩作用
Pub Date : 1900-01-01 DOI: 10.4236/pp.2023.148019
Belem-Kabré Esther, Nitiéma Mathieu, Odjo Blondine Saïdath, M. Oumarou, Y. Boubacar, Kaboré Boukaré, Somda Gaëtan Donzéo, Traoré Tata Kadiatou, K. Moumouni, I. Sylvain, Ouédraogo Moussa, Kabré Elie, Ouédraogo Noufou
Background: Anastatica hierochuntica L. (Brassicaceae) has been claimed to treat various conditions, including complicated childbirth. The principal ob-jective
背景:Anastatica hierochuntica L.(芸苔科)被认为可以治疗各种疾病,包括复杂的分娩。主要目标
{"title":"Phytochemical Analysis and Contractile Effects of Aqueous and Hydroethanolic Extracts of <i>Anastatica hierochuntica</i> L. (Brassicaceae) on the Isolated Uterus of Mice","authors":"Belem-Kabré Esther, Nitiéma Mathieu, Odjo Blondine Saïdath, M. Oumarou, Y. Boubacar, Kaboré Boukaré, Somda Gaëtan Donzéo, Traoré Tata Kadiatou, K. Moumouni, I. Sylvain, Ouédraogo Moussa, Kabré Elie, Ouédraogo Noufou","doi":"10.4236/pp.2023.148019","DOIUrl":"https://doi.org/10.4236/pp.2023.148019","url":null,"abstract":"Background: Anastatica hierochuntica L. (Brassicaceae) has been claimed to treat various conditions, including complicated childbirth. The principal ob-jective","PeriodicalId":432281,"journal":{"name":"Pharmacology &amp;amp; Pharmacy","volume":"30 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"122056053","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
CAR T Cell Immunotherapy That Revolutionary Breakthrough in Human Oncology Treatment: A Review CAR - T细胞免疫疗法在人类肿瘤治疗中的革命性突破:综述
Pub Date : 1900-01-01 DOI: 10.4236/pp.2022.1311036
Shammi Binte Bashar, Zannat Akhter, B. C. Saha, Md. Mushfiqul Islam Himaloy, U. Kulsum, Md. Rashedur Rahman
{"title":"CAR T Cell Immunotherapy That Revolutionary Breakthrough in Human Oncology Treatment: A Review","authors":"Shammi Binte Bashar, Zannat Akhter, B. C. Saha, Md. Mushfiqul Islam Himaloy, U. Kulsum, Md. Rashedur Rahman","doi":"10.4236/pp.2022.1311036","DOIUrl":"https://doi.org/10.4236/pp.2022.1311036","url":null,"abstract":"","PeriodicalId":432281,"journal":{"name":"Pharmacology &amp;amp; Pharmacy","volume":"175 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"128638059","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Effect of Food Thickeners on the Bitterness and Dissolution of Amlodipine Besilate Powder When Co-Administered with Thickeners to Patients with Dysphagia 食用增稠剂对吞咽困难患者苯磺酸氨氯地平粉苦味及溶出度的影响
Pub Date : 1900-01-01 DOI: 10.4236/pp.2022.1311034
Akiko Odanaga, Honami Kojima, Azumi Kabeya, Rio Uno, Miyako Yoshida, M. Habara, H. Ikezaki, T. Uchida
Purpose: The present research was performed to evaluate the effect of food thickeners on the bitterness and dissolution of bitter drugs when co-adminis-tered to patients with dysphagia. Methods: Amlodipine besilate (AMPB) powder was used as a model drug. Starch- and xanthan gum-based food thickeners were examined, with swallowing-aid jelly as a reference. The line-spread test (LST), texture prolife analysis (TPA) were done firstly. In related to AMPB powder mixed with food thickeners solution, a conventional dissolution test simulating the oral cavity was performed, the amlodipine (AMP) concentration and taste sensor output for dissolved medium versus time profiles were developed. The dissolution test at pH 1.2 and 4.5, representing typical gastric conditions for younger or elderly people, was performed in two kinds of thickener solution and swallowing-aid jelly those were mixed with AMPB powder. Results: LST demonstrated that xanthan gum-based food thickeners fulfilled the requirements for patients with dysphagia but that starch-based food thickeners did not. In TPA, hardness and adhesiveness decreased pro-portionally as the concentration increased for both kinds of food thickener. bioavailability in humans. The 7.1 and 4.7 (w/v) % starch-based thickener show bitterness inhibition under simulated oral cavity conditions and complete dissolution of AMP under simulated gastric conditions.
目的:研究食物增稠剂对吞咽困难患者联合用药时苦味药物的苦味和溶出度的影响。方法:以苯磺酸氨氯地平(AMPB)粉末为模型药物。以助吞胶为对照,研究了淀粉基和黄原胶基食品增稠剂。首先进行了线展试验(LST)和织构增殖分析(TPA)。针对与食品增稠剂溶液混合的氨氯地平粉末,进行了模拟口腔的常规溶出试验,研究了氨氯地平(AMP)在溶解介质中的浓度和味觉传感器输出随时间的变化曲线。将两种增稠剂溶液和助咽胶与AMPB粉混合,分别进行pH值为1.2和4.5的溶出试验,分别代表了年轻人和老年人典型的胃部状况。结果:LST表明黄原胶基食品增稠剂满足吞咽困难患者的要求,而淀粉基食品增稠剂不满足。在TPA中,两种食品增稠剂的硬度和黏附性随浓度的增加而成比例地降低。人类的生物利用度。7.1和4.7 (w/v) %淀粉基增稠剂在模拟口腔条件下表现出苦味抑制作用,在模拟胃部条件下表现出AMP的完全溶解作用。
{"title":"The Effect of Food Thickeners on the Bitterness and Dissolution of Amlodipine Besilate Powder When Co-Administered with Thickeners to Patients with Dysphagia","authors":"Akiko Odanaga, Honami Kojima, Azumi Kabeya, Rio Uno, Miyako Yoshida, M. Habara, H. Ikezaki, T. Uchida","doi":"10.4236/pp.2022.1311034","DOIUrl":"https://doi.org/10.4236/pp.2022.1311034","url":null,"abstract":"Purpose: The present research was performed to evaluate the effect of food thickeners on the bitterness and dissolution of bitter drugs when co-adminis-tered to patients with dysphagia. Methods: Amlodipine besilate (AMPB) powder was used as a model drug. Starch- and xanthan gum-based food thickeners were examined, with swallowing-aid jelly as a reference. The line-spread test (LST), texture prolife analysis (TPA) were done firstly. In related to AMPB powder mixed with food thickeners solution, a conventional dissolution test simulating the oral cavity was performed, the amlodipine (AMP) concentration and taste sensor output for dissolved medium versus time profiles were developed. The dissolution test at pH 1.2 and 4.5, representing typical gastric conditions for younger or elderly people, was performed in two kinds of thickener solution and swallowing-aid jelly those were mixed with AMPB powder. Results: LST demonstrated that xanthan gum-based food thickeners fulfilled the requirements for patients with dysphagia but that starch-based food thickeners did not. In TPA, hardness and adhesiveness decreased pro-portionally as the concentration increased for both kinds of food thickener. bioavailability in humans. The 7.1 and 4.7 (w/v) % starch-based thickener show bitterness inhibition under simulated oral cavity conditions and complete dissolution of AMP under simulated gastric conditions.","PeriodicalId":432281,"journal":{"name":"Pharmacology &amp;amp; Pharmacy","volume":"35 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"131868781","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Antibiotic Prescribing Patterns and Prevalence of Surgical Site Infections in Caesarean Section Deliveries at Two Tertiary Hospitals in Lusaka, Zambia 赞比亚卢萨卡两所三级医院剖宫产手术部位感染的抗生素处方模式和流行情况
Pub Date : 1900-01-01 DOI: 10.4236/pp.2022.138024
M. Kasanga, M. Chileshe, S. Mudenda, Raphael Mukosha, Maika Kasanga, V. Daka, Tobela Mudenda, M. Chisembele, J. Musuku, B. Solochi, Jian Wu
{"title":"Antibiotic Prescribing Patterns and Prevalence of Surgical Site Infections in Caesarean Section Deliveries at Two Tertiary Hospitals in Lusaka, Zambia","authors":"M. Kasanga, M. Chileshe, S. Mudenda, Raphael Mukosha, Maika Kasanga, V. Daka, Tobela Mudenda, M. Chisembele, J. Musuku, B. Solochi, Jian Wu","doi":"10.4236/pp.2022.138024","DOIUrl":"https://doi.org/10.4236/pp.2022.138024","url":null,"abstract":"","PeriodicalId":432281,"journal":{"name":"Pharmacology &amp;amp; Pharmacy","volume":"24 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"130637315","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Evaluation of the Safety and Efficacy of Extracts from the Leaves of Five Plants Used for the Treatment of Arterial Hypertension in Benin 贝宁五种植物叶提取物治疗高血压的安全性和有效性评价
Pub Date : 1900-01-01 DOI: 10.4236/pp.2022.1310027
O. Koukoui, S. Seton, M. Betira, J. Amagbegnon, F. Sonounameto, E. Assou, A. Sezan
{"title":"Evaluation of the Safety and Efficacy of Extracts from the Leaves of Five Plants Used for the Treatment of Arterial Hypertension in Benin","authors":"O. Koukoui, S. Seton, M. Betira, J. Amagbegnon, F. Sonounameto, E. Assou, A. Sezan","doi":"10.4236/pp.2022.1310027","DOIUrl":"https://doi.org/10.4236/pp.2022.1310027","url":null,"abstract":"","PeriodicalId":432281,"journal":{"name":"Pharmacology &amp;amp; Pharmacy","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"122276680","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Antidiabetic Potential of Carthamus oxycantha M.Bieb. Seeds in Alloxan Induced Diabetic Rats 红花的抗糖尿病潜能。四氧嘧啶诱导的糖尿病大鼠种子
Pub Date : 1900-01-01 DOI: 10.4236/pp.2022.136015
A. Abid, Hira Muzammel, H. Shafi, M. Nisa, Hassani Ali, Muhammad Afzal, N. Khan, Fahad Muzammil
{"title":"Antidiabetic Potential of <i>Carthamus oxycantha</i> M.Bieb. Seeds in Alloxan Induced Diabetic Rats","authors":"A. Abid, Hira Muzammel, H. Shafi, M. Nisa, Hassani Ali, Muhammad Afzal, N. Khan, Fahad Muzammil","doi":"10.4236/pp.2022.136015","DOIUrl":"https://doi.org/10.4236/pp.2022.136015","url":null,"abstract":"","PeriodicalId":432281,"journal":{"name":"Pharmacology &amp;amp; Pharmacy","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"122493898","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluation of the Fasciolicidal/Nematicidal Efficacy of an Intramuscular Combination of Clorsulon/Levamisole in Naturally Infected Dairy Cattle 克罗舒隆/左旋咪唑肌内联合对自然感染奶牛的筋膜虫/线虫杀虫效果评价
Pub Date : 1900-01-01 DOI: 10.4236/pp.2022.1311033
F. Ibarra-Velarde, Y. Vera‐Montenegro, Ignacio Olave-Leiva, Antonio Figueroa-Castillo, Irene Cruz Mendoza, JoaquÍn Ambía-Medina
The aim of the present study was to assess the fasciolicidal and nematicidal efficacy of a new combination of clorsulon/levamisole, which was formulated for intramuscular administration, in dairy cattle. For the study, sixteen Hols-tein-Freisian dairy cows were selected for inclusion in the trial based on finding Fasciola hepatica eggs or gastrointestinal nematodes (GIN) in the feces. Ten of these cows were naturally infected with F. hepatica, and 6 were naturally infected with GIN. On Day 0 (zero), all animals were treated with a combination of clorsulon (2.5 mg/kg/IM and levamisole (2.5 mg/kg/IM) administered at the dose recommended by the manufacturer (1 ml/20kg/bw). Subsequently, their feces were analyzed on days 0, 7, 14 and 21 post treat-ments by the Flukefinder sedimentation method and McMaster technique to determine the percentages of egg reduction in the animals, with reference to the egg load count on day 0. The results obtained in the current work indicated an efficacy of 100% that was determined by the percentage reduction of eggs of F. hepatica and/or GIN. This new fasciolicide/nematicide formulation exerted a remarkable effect and can be considered a new alternative to control F. hepatica and gastrointestinal worms in dairy cattle.
本研究的目的是评估克罗舒隆/左旋咪唑的新组合对奶牛的筋膜虫和线虫的杀灭效果,该组合是为肌肉注射而配制的。在本研究中,根据在粪便中发现肝片吸虫卵或胃肠道线虫(GIN)的情况,选择16头霍尔-泰-弗莱西亚奶牛纳入试验。其中10头牛自然感染肝原体,6头牛自然感染GIN。在第0天(零),所有动物均接受克罗sulon (2.5 mg/kg/IM)和左旋咪唑(2.5 mg/kg/IM)的联合治疗,剂量为制造商推荐的剂量(1ml /20kg/bw)。随后,采用Flukefinder沉降法和麦克马斯特技术,在处理后第0、7、14和21天对其粪便进行分析,以第0天的卵载量计数确定动物的卵减少百分比。在目前的工作中获得的结果表明,100%的功效是由减少肝炎F.和/或GIN卵的百分比决定的。该新型杀片筋膜虫/杀线虫剂制剂效果显著,可作为防治奶牛肝梭菌和胃肠道蠕虫的新选择。
{"title":"Evaluation of the Fasciolicidal/Nematicidal Efficacy of an Intramuscular Combination of Clorsulon/Levamisole in Naturally Infected Dairy Cattle","authors":"F. Ibarra-Velarde, Y. Vera‐Montenegro, Ignacio Olave-Leiva, Antonio Figueroa-Castillo, Irene Cruz Mendoza, JoaquÍn Ambía-Medina","doi":"10.4236/pp.2022.1311033","DOIUrl":"https://doi.org/10.4236/pp.2022.1311033","url":null,"abstract":"The aim of the present study was to assess the fasciolicidal and nematicidal efficacy of a new combination of clorsulon/levamisole, which was formulated for intramuscular administration, in dairy cattle. For the study, sixteen Hols-tein-Freisian dairy cows were selected for inclusion in the trial based on finding Fasciola hepatica eggs or gastrointestinal nematodes (GIN) in the feces. Ten of these cows were naturally infected with F. hepatica, and 6 were naturally infected with GIN. On Day 0 (zero), all animals were treated with a combination of clorsulon (2.5 mg/kg/IM and levamisole (2.5 mg/kg/IM) administered at the dose recommended by the manufacturer (1 ml/20kg/bw). Subsequently, their feces were analyzed on days 0, 7, 14 and 21 post treat-ments by the Flukefinder sedimentation method and McMaster technique to determine the percentages of egg reduction in the animals, with reference to the egg load count on day 0. The results obtained in the current work indicated an efficacy of 100% that was determined by the percentage reduction of eggs of F. hepatica and/or GIN. This new fasciolicide/nematicide formulation exerted a remarkable effect and can be considered a new alternative to control F. hepatica and gastrointestinal worms in dairy cattle.","PeriodicalId":432281,"journal":{"name":"Pharmacology &amp;amp; Pharmacy","volume":"87 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"133637982","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Research on the Path of Improving the Technological Innovation Ability of Chinese Pharmaceutical Industry Based on Technology 基于技术的中国医药产业技术创新能力提升路径研究
Pub Date : 1900-01-01 DOI: 10.4236/pp.2022.138022
Xinyun Gao, Yongfa Chen
Based on the perspective of professional knowledge and professional technology, this paper focuses on the path to improve the technological innovation ability on the technical level, and provides advice and reference for promoting the pharmaceutical industry to achieve the improvement of technological innovation ability and the structural upgrading of the entire industry. It is found that in the project approval process of innovation subject, the key is to realize the guiding role of market demand on the project approval process of scientific research. In the research and development of innovative drugs, it is necessary to focus on the adaptation and transformation of laboratory technology in scale-up production. In the process of innovation achievement delivery and transformation, the focus is to truly complete the extension from the patent application stage to the product launch stage.
本文基于专业知识和专业技术的视角,从技术层面探讨提升技术创新能力的路径,为促进医药行业实现技术创新能力的提升和整个行业的结构升级提供建议和参考。研究发现,在创新主体立项过程中,关键是要实现市场需求对科研立项过程的引导作用。在创新药物的研发中,必须注重实验室技术在规模化生产中的适应和转化。在创新成果交付和转化过程中,重点是真正完成从专利申请阶段到产品上市阶段的延伸。
{"title":"Research on the Path of Improving the Technological Innovation Ability of Chinese Pharmaceutical Industry Based on Technology","authors":"Xinyun Gao, Yongfa Chen","doi":"10.4236/pp.2022.138022","DOIUrl":"https://doi.org/10.4236/pp.2022.138022","url":null,"abstract":"Based on the perspective of professional knowledge and professional technology, this paper focuses on the path to improve the technological innovation ability on the technical level, and provides advice and reference for promoting the pharmaceutical industry to achieve the improvement of technological innovation ability and the structural upgrading of the entire industry. It is found that in the project approval process of innovation subject, the key is to realize the guiding role of market demand on the project approval process of scientific research. In the research and development of innovative drugs, it is necessary to focus on the adaptation and transformation of laboratory technology in scale-up production. In the process of innovation achievement delivery and transformation, the focus is to truly complete the extension from the patent application stage to the product launch stage.","PeriodicalId":432281,"journal":{"name":"Pharmacology &amp;amp; Pharmacy","volume":"6 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"114755248","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Pharmacology &amp;amp; Pharmacy
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1